Stephen Liu, Chief of Division of Hematology and Oncology at Georgetown Lombardi Comprehensive Cancer Center, shared on X:
“Dr. Sandip Patel provides an updated overview of immunotherapy in early stage NSCLC; compares and contrasts to melanoma.
Neoadjuvant and perioperative have been more consistent than adjuvant but many questions remain including approach to borderline resectable cases.”
You can also read:
